Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma

Background and study aims: In the past, there were long delays in the diagnosis of patients with cancer of the stomach or esophagus. The objective of this study was to describe current delays in the diagnosis and treatment of gastric and esophageal adenocarcinoma and to compare the findings with those from an historical control population treated at the same institutions 10 years earlier.
Patients and methods: Patients with biopsy-proven gastric cancer or esophageal adenocarcinoma who were treated at two academic medical centers in Germany between April and October 2003 were consecutively screened for eligibility to take part in the study. Medical charts for each patient were reviewed. Additional data were obtained via structured interviews. Main outcome measures were the total delay, and the delays related to patients themselves, to doctors, and to the hospital. Data were compared with those from a historic control group assessed in 1993.
Results: The median total delay for patients with gastric cancer (n = 104) was 3.5 months (range 0.3 - 29.6), and in patients with esophageal adenocarcinoma (n = 22) the total delay was significantly shorter (median 2.2 months, range 1.2 - 11.7; P < 0.05). Comparing these findings with those from an historic cohort of patients with gastric cancer (n = 100) revealed a significant decrease in the total delay (3.5 versus 8.0 months, P < 0.001).
Conclusions: The current findings indicate that delays in the diagnosis and treatment of gastric cancer have become significantly shorter within the last 10 years as our understanding of and ability to treat this form of cancer have improved.

References

• 1 Mikulin T, Hardcastle J D. Gastric cancer - delay in diagnosis and its causes.  Eur J Cancer Clin Oncol. 1987;  23 1683-1690
• 2 Martin I G, Young S, Sue-Ling H, Johnston D. Delays in the diagnosis of oesophagogastric cancer: a consecutive case series.  Br Med J. 1997;  314 467-470
• 3 Siewert J R, Fink U. Commentary: Britain does better than Germany before patients reach hospital.  Br Med J. 1997;  314 471
• 4 Look M, Tan Y Y, Vijayan A. et al . Management delays for early gastric cancer in a country without mass screening.  Hepatogastroenterology. 2003;  50 873-876
• 5 Herrmann C, Buss U. (eds) .Hospital anxiety and depression scale: HADS-D; deutscheVersion; ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin. 1. Aufl. Bern; Huber 1995
• 6 Rief W, Hiller W, Geissner E, Fichter M M. Hypochondrie: Erfassung und erste klinische Ergebnisse.  Zeitschr Klin Psych. 1994;  23 34-42
• 7 Kobler E, Nuesch H J, Amman R. et al . Delay in diagnosis of stomach neoplasms: consequences in 534 cases.  Schweiz Med Wochenschr. 1976;  106 311-312
• 8 Devesa S S, Blot W J, Fraumeni J F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States.  Cancer. 1998;  38 2049-2053
• 9 Department of Health .Guidance on commissioning cancer services. Improving outcomes in upper gastro-intestinal cancers - the manual. London; Department of Health 2001
• 10 Kapoor N, Bassi A, Sturgess R, Bodger K. Predictive value of alarm features in a rapid access upper gastrointestinal cancer service.  Gut. 2005;  54 40-45
• 11 Bramble M G, Suvakovic Z, Hungin A PS. Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy.  Gut. 2000;  46 464-467
• 12 Wayman J, Hayes N, Raimes S A, Griffin S M. Prescription of proton pump inhibitors before endoscopy. A potential cause of missed diagnosis of early gastric cancers.  Arch Fam Med. 2000;  9 385-388
• 13 Lordick F, Stein H J, Peschel C, Siewert J R. Neoadjuvant therapy in oesophago-gastric cancer.  Br J Surg. 2004;  91 540-551
• 14 Veldhuyzen van Zanten S. Upper gastrointestinal alarms: the 2-week rule.  Lancet. 2005;  365 2163-2164